Limits on Medicare's ability to control rising spending on cancer drugs. Academic Article uri icon

Overview

publication date

  • January 27, 2009

Research

keywords

  • Antineoplastic Agents
  • Drug Costs
  • Medicare
  • Reimbursement Mechanisms

Identity

Scopus Document Identifier

  • 59749092456

Digital Object Identifier (DOI)

  • 10.1056/NEJMhpr0807774

PubMed ID

  • 19176475

Additional Document Info

volume

  • 360

issue

  • 6